What does BRCA1 actually mean?
A thread through the evidence — ClinVar, gnomAD, ClinGen, and GTEx.
Data at a glance
Quantitative view across ClinVar, gnomAD, GTEx, and ClinGen.
GTEx is featured first. Use the selector to move across data sources.
GTEx top tissue expression
Median TPM across top tissues.
ClinVar classification mix
16,061 submitted variants for this gene.
Radial view shows each category as a percent of total submitted variants (16,061). ClinVar categories can overlap, so row percentages may sum above 100%.
Pathogenic
14,306 (89%)Likely pathogenic
0 (0%)VUS
0 (0%)Likely benign
0 (0%)Benign
8,335 (52%)Conflicting
0 (0%)Other / unclassified
0 (0%)14,306
Pathogenic + likely
0
VUS
0
Other / unclassified
gnomAD profile
Constraint metrics plus full-gene variant distribution across GRCh38 coordinates.
pLI0.00
Higher suggests stronger LoF intolerance
LOEUF0.928
Lower indicates stronger LoF constraint
Mis-Z1.73
Higher can suggest missense depletion
Genome-mapped variant landscape
7,287 shown
This is a positional map of gnomAD population variation, not a pathogenicity map. For pathogenic vs VUS, use the ClinVar panel.
chr17:43,044,295-43,170,245 on GRCh38
Display: All gnomAD variants. Click a bar to inspect that genomic interval.
Binned from the full gene variant set to preserve complete counts while keeping UI readable.
ClinGen gene-disease validity
Evidence strength assigned by ClinGen curation.
Definitive
Evidence strength100%
Variation
BRCA1 has 16,061 variants submitted to ClinVar (chromosome 17). Among them, 14306 are classified as pathogenic or likely pathogenic, and 0 remain Variants of Uncertain Significance. Each variant is a thread in the story — some we understand, many we're still learning.
Interpretation
Interpretation of genetic variants is an evolving science. What we know about BRCA1 today may shift as new evidence emerges.
Constraint
gnomAD's constraint metrics tell us how tolerant BRCA1 is to different types of mutations in the general population. A LOEUF score of 0.93 suggests moderate tolerance. This is indirect evidence, but it's powerful: evolution has been running this experiment for millions of years.
Expression
GTEx data shows where BRCA1 is most active in the body. Top tissues: Cells EBV-Transformed Lymphocytes (20.9 TPM), Testis (10.6 TPM), Cells Cultured Fibroblasts (7.6 TPM). Where a gene is expressed often aligns with where pathogenic variants cause disease — though the gene isn't silent elsewhere; it may play roles across many cell types.
Meaning
So what does it all mean? BRCA1 is a gene we're still learning about. 14306 variants are classified as pathogenic or likely pathogenic — evidence that's strong and actionable when it applies to you. 0 variants remain uncertain. That's the honest state of genomic medicine: if you carry a pathogenic BRCA1 variant, the evidence speaks clearly. If you carry a VUS, the evidence is still accumulating. Either way, you deserve to understand what the science actually says.